V. Mikl, M. Azizzadeh, M.-K. Breyer, K. ten Haaf, V. Ritschel, J. Simon, T. StammStudy protocol: a systematic review on use and impact of risk-prediction models in low-dose computed tomography lung cancer screening

A. Spary, A. Pracher-Biedermann, P. Köppel, B. Schwarz, H. Halbmayr, M. Mustak-BlaguszDatenauswertung 2024 der Tabakfreiberatung und Tabakentwöhnung (Minimal Data Sets) der PV ZAR Graz, ambulante Rehabilitation der Pensionsversicherung

A. Busau, E. Ahmic, P. Swatek, I. Mykoliuk, A. Roj, A. Maier, J. LindenmannIntrapulmonary intra-arterial malposition of a port catheter – an exceptionally rare complication

H.-J. Huang, R. Breyer-Kohansal, K. Niespodziana, C.J.M. Lim, M.-K. Breyer, R. Valenta, S. Hartl, Allergochip Working GroupMolecular IgE sensitization profiling with micro-arrayed allergen molecules in adult asthmatics from the LEAD cohort: A precision medicine approach

D. Lang, W. Stoiber, A. Obermayer, G. Shao, B. Kaiser, R. Langer, B. LamprechtEndothelial cell basement membrane alterations in transmission electron microscopy of transbronchial lung cryobiopsy samples in fibrotic interstitial lung disease patients

P. Waked, G. Kovacs, V. Foris, F. Moazedi-Fürst, E. Osto, B. Obermayer-Pietsch, V. BiasinTestosterone – a hormonal modulator of lung fibrosis?

S. Sahanic, C. Dünser, R. Hilbe, T. Sonnweber, G. Weiss, I. TancevskiUnveiling Eosinophil Plasticity: Distinct Transcriptional Signatures in Eosinophilic Asthma and their Modulation by IL-5 Blockade

E. Fließer, T. Lins, K. Jandl, A. Birnhuber, N. Kneidinger, J. Lindenmann, C. Aigner, A. Benazzo, G. KwapiszewskaMapping Endothelial Plasticity in Lung Fibrosis: Insights from in-vivo Lineage Tracing

C. Dünser, R. Hilbe, S. Sahanic, C. Gollmann-Tepeköylü, T. Sonnweber, I. TancevskiInvestigating the Biglycan-TLR3-IFNAR1 Axis in Pulmonary Fibrosis

R. Hilbe, C. Dünser, S. Sahanic, T. Sonnweber, I. Tancevski, G. WeissCost-Effective Production of Recombinant Human CSF1 Using a Stable CHO Cell Expression System with PiggyBac Transposition

A. Ananich, C. Dünser, R. Hilbe, T. Sonnweber, S. Sahanic, G. Weiss, I. TancevskiEffects of NF-κB Inhibition on Chronic Airway Epithelial Inflammation and Cell Migration

J.L. Berg, K. Jandl, T. Lins, I. Borek, A.C. Mutgan, D. Maleczek, C. Aigner, A. Benazzo, M. Wygrecka, T. Žagar, M. Novinec, N. Kneidinger, G. KwapiszewskaThe MMP14-derived matrikine endostatin is an active driver of vascular remodeling in pulmonary arterial hypertension

H. Dörfler, J. Daniels, S. Wadekar, Q. Pagneux, D. Ladage, G. Greiner, O. Assadian, R. Boukherroub, S. SzuneritsMolecular Detection of SARS-CoV-2 Viral Particles in Exhaled Breath Condensate via Engineered Face Masks

M.T. Grasl, A. Karimi, A. Agusti, R. Faner, M.-K. Breyer, R. Breyer-KohansalLung function changes in children and adolescence in the LEAD general population cohort

T.L. Mraz, C.J. Lim, E.F. Wouters, C.G. Irvin, D.A. Kaminsky, S. Hartl, M.-K. Breyer, R. Breyer-KohansalRespiratory Mechanics of preserved ratio impaired spirometry (PRISm): data from the LEAD study

T.L. Mraz, C.J. Lim, E.F. Wouters, C.G. Irvin, D.A. Kaminsky, S. Hartl, M.-K. Breyer, R. Breyer-KohansalPhysiological and clinical characterization of subjects with new PRISm: data from the LEAD study

R. Gloeckl, P.W. Jones, D. Kroll, I. Jarosch, T. Schneeberger, P. Schmidt, C.F. Vogelmeier, K. Kenn, R. KoczullaThe COPD Exacerbation Recognition Tool (CERT) can predict acute exacerbations one day before clinical diagnosis

M. Azizzadeh, E.F.M. Wouters, C.J.M. Lim, T. Mraz, A. Ofenheimer, A. Dal Grande, S. Hartl, R. Breyer-Kohansal, M.-K. BreyerAssociation of triglyceride-glucose index and lung function impairment: data from the LEAD Study

M. Azizzadeh, E.F.M. Wouters, A. Karimi, D.J.A. Janssen, B. Spaetgens, S. Hartl, R. Breyer-Kohansal, M.-K. BreyerThe added value of lung function in allostatic load scoring for mortality risk assessment: data from the Austrian LEAD Study

K. Orasche, T. John, P. Douschan, V. Foris, N. Kneidinger, G. Kovacs, K. ZederMale sex is associated with more severe pulmonary hypertension and worse outcome in COPD at index presentation

A. Lenoir, R. Buhl, C. Mümmler, J. Behr, N. Kneidinger, R. Ehmann, E. Hamelmann, A. Holtdirk, M. Idzko, M. Jandl, F. Kässner, O. Schmidt, C. Schulz, D. Skowasch, C. Taube, S. Korn, K. Milger, GAN Study groupChoosing and switching biologics for patients with severe asthma – real-world evidence from the GAN severe asthma registry

F. Prüfer, M. Kaiserseder, V. Grote, E. Untersmayr, R.H. ZwickPrevalence of ME/CFS Phenotype in Post-COVID-19 Outpatient Rehabilitation

A. Horner, S. Raghumahanti, K. Krist, B. Kaiser, B. LamprechtEligibility of COPD Patients for Biologic Therapy – an Analysis of the JKU-CC study

H. Abozid, A. Karimi, M.-K. Breyer, D. Kaminksy, A.F. Amaral, E.F. Wouters, R. Breyer-KohansalPrevalence and risk factors of spirometric small airways disease in a general population: data from the LEAD study

H. Abozid, M.-K. Breyer, E.F. Wouters, A.F. AmaralChronic cough and quality of life in a multinational study

V.E. Mikl, M. Azizzadeh, R. Breyer-Kohansal, G.-C. Funk, A. Valipour, B. Riedl, T. Stamm, H. Prosch, M.-K. BreyerStudy Protocol: Lung Cancer Early Detection Program – results from the population based Vienna Health Study (LEAD)

A. Karimi, M. Azizzadeh, H. Abozid, S. Hartl, M.K. Breyer, E.F. Wouters, R. Breyer-KohansalMachine learning for early detection of airflow obstruction in a general population: data from the Austrian LEAD Study

P. Etzel, B. Kaiser, D. Lang, B. LamprechtAntifibrotic treatment for fibrosing ILD in Austria - prescription and dosing characteristics according to health insurance claims data 2019-2024

K. Krist, S. Raghumahanti, B. Kaiser, B. Lamprecht, A. HornerClinical Characteristics and Exacerbation Frequency in COPD Patients: Impact of FENO level- an Analysis of the JKU-CC study

T. Klemm, S. Scaglione, A. Tana, A. Ing, D.P. Steinfort, C.M. Orton, K. Klooster, J.P. Williamson, J.J. Christie, J.L. Garner, T.D. Koster, K. Welz, M. van Dijk, P.L. Shah, D.-J. Slebos, A. ValipourAirway lumen patency improvements from baseline to 6 months in patients with emphysema-related hyperinflation treated with a novel self-expanding nitinol airway scaffold

S. Gobetz, M. PichalTRIAP: Assessing the adherence of COPD patients to extra-fine Single Inhaler-Triple Therapy (efSITT) using BDP/FF/GB in Austria - observational, multicentre, open-label, non-interventional study (NIS)

G. Shao, B. Kaiser, M. Gabriel, B. Lamprecht, D. LangPeripheral blood biomarkers are associated with volume-based 18F-FDG PET/CT variables and pulmonary function in sarcoidosis patients

C.J.M. Helk-Lim, O. Helk, S. Hartl, M.-K. Breyer, E.F.M. Wouters, R. Breyer-KohansaThe effect of adiposity markers and lung volumes on FeNO: the LEAD study.

C.J.M. Lim, T. Mraz, C.G. Irvin, D.A. Kaminsky, M.-K. Breyer, E.F.M. Wouters, R. Breyer-Kohansal,Predictive markers for progression from PRISm to airflow limitation

S. Raghumahanti, K. Krist, B. Kaiser, B. Lamprecht, A. HornerClinical Characteristics and Exacerbation Frequency in COPD Patients: Impact of Vitamin D Status - an Analysis of the JKU-CC study

H. Abeln, T. John, G. Linnemann, V. Foris, N. Kneidinger, G. Kovacs, V. Stadlbauer, R. Stauber, P. DouschanHyperdynamic right ventricular function and pulmonary circulation and its impact on long term outcome in patients with chronic liver disease

Y. Merza, A. Papaporfyriou, C. Bal, M. Brunner, D.-M. Denk-Linnert, E. Tschernko, M. Idzko, D. GompelmannSafety of bronchoscopy in patients with ENT cancers

V. Pirklbauer, P. Etzel, M. Hohn, B. Kaiser, B. Lamprecht, D. LangClinical Characteristics and Outcomes of Super-Responders to Immune Checkpoint Inhibitor Therapy in Advanced Non-Small Cell Lung Cancer

S. Stoshikj, A. Renner, D. Boryshchuk, C. Bal, D. Skowasch, K. Milger, C. Schulz, M. Jandl, R. Ehmann, O. Schmidt, R. Buhl, E. Hamelmann, C. Taube, S. Korn, M. IdzkoInfluence of Comorbidities on Long-term Clinical Outcomes in Severe Asthma: Insights from the German Asthma Net (GAN)

S. Stoshikj, A. Renner, C. Krall, C. Bal, K. Milger, C. Schulz, M. Jandl, R. Ehmann, O. Schmidt, R. Buhl, E. Hamelmann, C. Taube, D. Skowasch, S. Korn, M. IdzkoReduction of Inhaled Corticosteroids After Biologic Therapy Initiation in Severe Asthma: Prevalence and Impact in the German Severe Asthma Registry

I. Robinson, V. Rodriguez, D Rosenthaler, H Fabikan, C Weinlinger, O Illini, L Ay, D Krenbek, K Kirchbacher, N Müser, M. Breyer, R Breyer-Kohansal, G. Funk, A Valipour, M. HochmairClinicopathological difference in lung squamous cell carcinoma with and without mutation

U.C. Rieder, F. Vafai-Tabrizi, G.-C. FunkLungenpuls zum sonographischen Pneumothoraxauschluss: B-Bild, M-Mode oder Power-Doppler?

K. Breitenecker, O. Illini, H. Fabikan, A.S. Lang-Stöberl, D. Krenbek, C. Weinlinger, D. Rosenthaler, S. Watzka, A. Valipour, M. HochmairMultidisciplinary treatment of advanced or metastatic ALK-positive non-small cell lung cancer: Real-world data on Brigatinib combined with local therapy

A. Renner, S. Stoshikj, E. Hamelmann, D. Skowasch, C. Schulz, M. Jandl, O. Schmidt, K. Milger, R. Ehmann, C. Taube, S. Korn, R. Buhl, M. IdzkoDupilumab improves long-term asthma control in German patients with severe asthma: Real-world data

J. Krainer-Jacobs, O. Illini, A. Lang-Stöberl, H. Fabikan, C. Weinlinger, D. Rosenthaler, A. Valipour, M. HochmairVery first real-world data on zongertinib use in non-small cell lung cancer patients with HER2 mutations: A brief report

A. van Egmond-Fröhlich, C. Jaquelin, F. KnippHigh pressure drop-off when mechanical insufflation-exsufflation (MIE) is used via endotracheal tubes must be compensated by increasing MIE pressures

T. John, L. Neuhuber, P. Douschan, V. Foris, K. Zeder, G. Bachmaier, H. Olschewski, N. Kneidinger, G. KovacsThe Clinical Relevance of Unclassified Pulmonary Hypertension

N. Hummel, I. TancevskiWissen über Risikofaktoren für Exazerbationen und demografische Merkmale bei COPD-Patient:innen in Tirol- Eine Studie aus Tirol

A. van Egmond-Fröhlich, C. Jaquelin, F. KnippDie Hustenspitzenflussgeschwindigkeit ist alters- und geschlechtsunabhängig und dies erlaubt Grenzwerte für den Hustenspitzenfluss für alle Kinder zu berechnen

Y. Heimbach-Weber, M. Rothensteiner, S. Baier-Grabner, F. Götzinger, M. Langthaler, A. Zacharasiewicz, M. TebrueggePulmonary tuberculosis with secondary dissemination potentially masked by treatment with a 3rd generation cephalosporin

F. Walter, O. Illini, H. Fabikan, V.M. Rodriguez, C. Weinlinger, M. Hochmair, J. Krainer, D. Rosenthaler, L. Ay, T. Klikovits, B. Danzl-Erne, M.-K. Breyer, R. Breyer-Kohansal, G.-C. Funk, A. Valipour, S. WatzkaOncological management of patients with potentially curative high-grade neuroendocrine lung cancer: a real-world analysis from the LALUCA registry

I. Birker, B. Kaiser, B. Lamprecht, D. LangPatient characteristics and prognosis in hypersensitivity pneumonitis patients according to diagnostic confidence levels – a registry-based retrospective study

P. Etzel, A. Habringer, B. Lamprecht, D. LangDiagnostic Challenges in VEXAS Syndrome: IgG4-RD and Vasculitis as Relevant Differential Diagnoses

P. Etzel, V. Pirklbauer, M. Hohn, B. Kaiser, B. Lamprecht, D. LangImmune-Related Adverse Events in Long-Term Responders to Immunotherapy in NSCLC: Predictors and Clinical Impact

J. Krainer-Jacobs, V.M. Rodriguez, D. Rosenthaler, H. Fabikan, C. Weinlinger, M. Hochmair, O. Illini, L. Ay, D. Krenbek, K. Kirchbacher, N. Müser, M.-K. Breyer, R. Breyer-Kohansal, G.-C. Funk, A. ValipourTreatment landscape in lung cancer: a real-world overview from the LALUCA registry

D. Rosenthaler, V.M. Rodriguez, H. Fabikan, C. Weinlinger, M. Hochmair, O. Illini, D. Krenbek, K. Kirchbacher, N. Müser, J. Krainer-Jacobs, M.-K. Breyer, R. Breyer-Kohansal, G.-C. Funk, A. ValipourLALUCA 2025 – Updates on a Prospective Multicenter Real-World Registry on Austrian Lung Cancer Care

A. Simeon, L. Horvath, C. Duftner, T. Sonnweber, G. Weiss, I. TancevskiPleuroparenchymal Fibroelastosis (PPFE) and Challenges in Differential Diagnosis: A Case Report

S. Miut, B. Kaiser, B. Lamprecht, D. LangAssociation of 6-Minute Walk Test biomarkers with baseline characteristics and disease progression in a cohort of fibrotic ILD patients

M.R. Gysan, K. Kastrati, S. Pochepnia, A. Lehmann, S. Lee, A. Renner, C. Bal, A. Papaporfyriou, C. Milacek, L. Antoniewicz, S. Metekol, M. Kramer, L. John, Z. Kargarpour, I. Aykara, P. Weber, K. Anderle, H.P. Kiener, M. Bonelli, D. Mrak, D. Aletaha, A. El-Gazzar, D. Gompelmann, M. Idzko, H. Lechner-RadnerBronchoalveolar lavage lymphocytosis as a predictor of progression in connective tissue disease-associated interstitial lung disease

B. Sabic, P. Raidl, J. Scharhag, L. Ernst, V. Peresich, B. Rogi, K. VonbankAgreement between different methods describing individual training intensities in pulmonary patients

M. Kneussl, G. Funk, A. SteinerPrimary Melanoma in the Lung and/or Pleura